Showing 981 - 1,000 results of 118,418 for search '(( 5 ((ppm decrease) OR (a decrease)) ) OR ( a ((nn decrease) OR (mean decrease)) ))', query time: 1.53s Refine Results
  1. 981

    Overexpression of cathepsin K in mice decreases collagen deposition and lung resistance in response to bleomycin-induced pulmonary fibrosis-5 by Mrigank Srivastava (94935)

    Published 2011
    “…The data are shown as mean ± SD of at least n = 10 mice per group and time point. * indicates significant increase (< 0.05) compared to cathepsin K transgenic mice. + indicates significant decrease (< 0.05) compared to the respective mock-treated mice.…”
  2. 982
  3. 983
  4. 984
  5. 985
  6. 986
  7. 987

    Decreased production of antiviral factors in patients infected with SARS-CoV-2 due to reduced TLR7 expression by Julia Cataldo Lima (22811497)

    Published 2025
    “…<p>The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic presents a major global health challenge. …”
  8. 988
  9. 989
  10. 990
  11. 991

    IL-8 secretion decreased from TLR5 silenced (siRNA) Caco-2BBe cells exposed to flagellin. by Tonyia Eaves-Pyles (344135)

    Published 2013
    “…<p><b>A. </b><i>S. dublin</i> flagellin was added to the AP or BL surface of polarized Caco-2BBe cells where TLR5 was knocked down using siRNA. …”
  12. 992
  13. 993
  14. 994

    Administration of anti-IL-11 antibodies decreases neutrophil influx in the lungs of TB-infected mice<sup>*</sup>. by Marina A. Kapina (249466)

    Published 2013
    “…Results are presented as summarized mean ± SD for all animals.</p>a<p>For F4/80<sup>+</sup> macrophages and Ly-6G<sup>+</sup> PMN: per cent of the total cell count; for B- and T-lymphocytes: per cent of the population gated for the lymphocyte size. …”
  15. 995

    Efficacy and Acceptability of Glycemic Control of Glucagon-Like Peptide-1 Receptor Agonists among Type 2 Diabetes: A Systematic Review and Network Meta-Analysis by Zhixia Li (2736331)

    Published 2016
    “…Dulaglutide, exenatide long-acting release (exe_lar), liraglutide and taspoglutide had significant lowering effect when compared with sitagliptin (HbA1c<7.0%) and insulin (HbA1c<6.5%). Finally, according to SUCRAs, placebo, thiazolidinediones and albiglutide had the best decrease effect on hypoglycemia; sulphanylureas, sitagliptin and insulin decrease the incidence of treatment discontinuation most; exe_lar and dulaglutide had the highest impact on glycemic level among 13 treatments.…”
  16. 996
  17. 997
  18. 998
  19. 999
  20. 1000